2026 Liquid Biopsy for Precision Oncology Summit Session
Today, Matthew Oberley, MD, PhD, Chief Clinical Officer at Caris Life Sciences, explained how WES-based reporting is expanding to include pharmacogenomic and emerging biomarkers and how CHIP-aware liq…
Article · @carisls